Merck and Pfizer Pull PR Coup With Corning Glass Partnership
This time, when Donald Trump hosted an event with two Big Pharma CEOs, the topic wasn’t drug pricing: it was jobs in American manufacturing, tied to a new, stronger glass vial. But it also looks like an early case study in effective engagement with an unpredictable White House.
You may also be interested in...
The US president made what seemed to be a retaliatory statement about high drug prices after Merck CEO Ken Frazier resigned from his jobs council.
The news that the Biden Administration is considering asking Robert Califf to return as Commissioner of the US FDA is the latest twist in a most unusual transition process at the agency. But one message seems abundantly clear: the White House is perfectly happy with FDA as it is.
Medicare Payment Advisory Commission also considering reviving least costly alternative policy in some way, but remains relatively hesitant about changes to ASP+6%.